Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075046 | SCV000106045 | pathogenic | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Large deletion |
Invitae | RCV000075046 | SCV000563809 | pathogenic | Lynch syndrome | 2016-11-02 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon 1 of the MLH1 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the MLH1 gene. This is expected to result in an absent or disrupted protein product. Loss-of-function variants in MLH1 are known to be pathogenic. Deletions of MLH1 exon 1 have been reported in the literature in individuals affected with colorectal cancer (PMID: 16941473, 15949572, 16807412). For these reasons, this variant has been classified as Pathogenic. |